Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

BCTC

BCTC is an orally active current inhibitor of vanilloid receptor type 1 (VR1) . BCTC is a transient receptor potential cation channel subfamily M member 8 (TRPM8) and transient receptor potential vanilloid 1 (TRPV1) antagonist. BCTC is an insulin sensitizer and secretor. BCTC has anticancer and analgesic effects[1][2][3][4][5].

Product Specifications

CAS Number

393514-24-4

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

CGRP Receptor; Insulin Receptor; TRP Channel

Type

Reference compound

Related Pathways

GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling; Protein Tyrosine Kinase/RTK

Applications

Cancer-programmed cell death

Field of Research

Cancer; Metabolic Disease; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/BCTC.html

Purity

99.66

Solubility

DMSO : ≥ 50 mg/mL

Smiles

O=C(N1CCN(C2=NC=CC=C2Cl)CC1)NC3=CC=C(C(C)(C)C)C=C3

Molecular Formula

C20H25ClN4O

Molecular Weight

372.89

Precautions

H302, H315, H319, H335

References & Citations

[1]Liu T, et al. Anti-tumor activity of the TRPM8 inhibitor BCTC in prostate cancer DU145 cells. Oncol Lett. 2016 Jan;11 (1) :182-188. |[2] Pomonis JD, et al. N- (4-Tertiarybutylphenyl) -4- (3-cholorphyridin-2-yl) tetrahydropyrazine -1 (2H) -carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain. J Pharmacol Exp Ther. 2003 Jul;306 (1) :387-93.|[3]Kanai Y, et al. Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats. Neuropharmacology. 2005 Dec;49 (7) :977-84. |[4] Nie C, et al. Study on chemical modification and analgesic activity of N- (4-tert-butylphenyl) -4- (3-chloropyridin-2-yl) piperazine-1-carboxamide. Eur J Med Chem. 2020 May 15;194:112236. |[5]Tanaka H, et al. Enhanced insulin secretion and sensitization in diabetic mice on chronic treatment with a transient receptor potential vanilloid 1 antagonist. Life Sci. 2011 Mar 14;88 (11-12) :559-63.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

Zfp639 (NM_144519) Mouse Tagged ORF Clone
MR207772 10 µg

Zfp639 (NM_144519) Mouse Tagged ORF Clone

Sign In for Pricing
View Details
Anti-p53 Antibody
MBS4156556-01 0.1 mL

Anti-p53 Antibody

Sign In for Pricing
View Details
Anti-p53 Antibody
MBS4156556-02 5x 0.1 mL

Anti-p53 Antibody

Sign In for Pricing
View Details
Mouse Tissue Inhibitors Of Metalloproteinase 3 (TIMP3) ELISA Kit
MBS4502905-01 48 Tests

Mouse Tissue Inhibitors Of Metalloproteinase 3 (TIMP3) ELISA Kit

Sign In for Pricing
View Details
Mouse Tissue Inhibitors Of Metalloproteinase 3 (TIMP3) ELISA Kit
MBS4502905-02 96 Tests

Mouse Tissue Inhibitors Of Metalloproteinase 3 (TIMP3) ELISA Kit

Sign In for Pricing
View Details
Mouse Tissue Inhibitors Of Metalloproteinase 3 (TIMP3) ELISA Kit
MBS4502905-03 5x 96 Tests

Mouse Tissue Inhibitors Of Metalloproteinase 3 (TIMP3) ELISA Kit

Sign In for Pricing
View Details